Topical Antimicrobial Ointments for Blisters in Pediatric Patients
Mupirocin 2% topical ointment is the recommended first-line antimicrobial for preventing infection in pediatric patients with blisters and minor skin infections. 1, 2
First-Line Treatment Options
- Mupirocin 2% topical ointment should be applied three times daily to blister sites for 7-10 days to prevent secondary bacterial infection 1, 2, 3
- Mupirocin has demonstrated excellent clinical efficacy rates of 78-96% in pediatric populations with minor skin infections 3
- Mupirocin is highly effective against the most common skin pathogens, including Staphylococcus aureus (including MRSA) and Streptococcus pyogenes 4
Clinical Evidence Supporting Mupirocin Use
- FDA clinical trials showed mupirocin ointment achieved 78% clinical efficacy in pediatric patients (ages 2 months to 15 years) with impetigo compared to 36% with placebo 3
- In direct comparison studies, mupirocin demonstrated equivalent clinical efficacy to oral erythromycin (96% vs 78.5%) but with superior bacterial eradication and fewer side effects 3, 5
- Mupirocin delivers high drug concentrations directly to the infection site while avoiding systemic exposure 4
Alternative Topical Options
- Chlorhexidine antiseptic washes can be used as an adjunctive therapy to help prevent infection in blisters 6, 7
- Diluted bleach baths (1 teaspoon per gallon of bath water for 15 minutes twice weekly) may be considered for patients with recurrent skin infections 2
- Fusidic acid can be considered as an alternative topical antibiotic in cases where mupirocin resistance is suspected 8
Important Considerations and Precautions
- Blisters should generally be left intact when possible to prevent secondary bacterial infection 9
- If blisters are large or in functionally problematic areas (e.g., soles of feet), they may be pierced with a sterile needle to release fluid while leaving the blister roof intact 9
- For extensive areas of erosion, antiseptics such as potassium permanganate baths or antiseptic-containing bath oils may help dry lesions and prevent infection 9
- Painful eroded areas may be covered with low-adhesion dressings held in place with soft elasticated viscose 9
Monitoring and Follow-up
- Monitor for signs of increasing erythema, warmth, pain, or purulent drainage that may indicate secondary infection requiring systemic antibiotics 1, 2
- Be aware of emerging resistance to topical antimicrobials, with studies showing approximately 10% resistance rates to mupirocin among S. aureus isolates 10
- Consider obtaining bacterial cultures if infection is suspected or if there is inadequate response to initial topical therapy 1
Systemic Therapy Considerations
- If secondary infection develops or for more extensive infections, systemic antibiotics may be necessary 2
- For systemic therapy in pediatric patients, first-line options include: